[Diagnosis and therapy of 6 hereditary, to mental-deficiency-leading, metabolic disorders. 2].
D000208:Acute Disease; D003937:Diagnosis, Differential; D005690:Galactose; D005693:Galactosemias / Q000175:diagnosis / Q000453:epidemiology; D005860:Germany, West; D006639:Histidine / Q000097:blood; D006711:Homocystine / Q000652:urine; D006712:Homocystinuria / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D008607:Intellectual Disability / Q000209:etiology*; D008375:Maple Syrup Urine Disease / Q000175:diagnosis / Q000453:epidemiology; D008403:Mass Screening; D008661:Metabolism, Inborn Errors / Q000175:diagnosis* / Q000178:diet therapy / Q000188:drug therapy / Q000453:epidemiology; D008715:Methionine / Q000097:blood; D010770:Phosphotransferases / Q000172:deficiency
D006711:Homocystine; D006639:Histidine; D008715:Methionine; D010770:Phosphotransferases; D005690:Galactose
Diagnose und Therapie sechs erbbedingter, zu Schwachsinn führender Stoffwechselstörungen. Teil 2